{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T01:56:20Z","timestamp":1776995780665,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.bone.2009.01.011","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T04:56:22Z","timestamp":1232772982000},"page":"S26-S29","source":"Crossref","is-referenced-by-count":32,"special_numbering":"S1","title":["Vitamin D and vascular calcification in chronic kidney disease"],"prefix":"10.1016","volume":"45","author":[{"given":"Masahide","family":"Mizobuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Koiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriko","family":"Kinugasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadao","family":"Akizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2009.01.011_bib1","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1053\/j.ajkd.2003.12.005","article-title":"Vascular calcification in chronic kidney disease","volume":"43","author":"Goodman","year":"2004","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bone.2009.01.011_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1525-139X.2007.00255.x","article-title":"The vascular biology of calcification","volume":"20","author":"Shroff","year":"2007","journal-title":"Semin. Dial"},{"key":"10.1016\/j.bone.2009.01.011_bib3","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1161\/01.CIR.0000160353.27927.70","article-title":"25-hydroxyvitamin D3\u20131alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds","volume":"111","author":"Somjen","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.bone.2009.01.011_bib4","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0006-291X(88)80439-X","article-title":"1,25-Dihydroxyvitamin D3 stimulates 45Ca2+-uptake by cultured vascular smooth muscle cells derived from rat aorta","volume":"152","author":"Inoue","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2009.01.011_bib5","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/S0024-3205(02)01473-X","article-title":"1,25-dihydroxyvitamin D3 receptor is upregulated in aortic smooth muscle cells during hypervitaminosis D","volume":"70","author":"Rajasree","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.bone.2009.01.011_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.atherosclerosis.2005.06.046","article-title":"Effects of Vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells","volume":"186","author":"Wu-Wong","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bone.2009.01.011_bib7","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/jcb.21133","article-title":"VDR-mediated gene expression patterns in resting human coronary artery smooth muscle cells","volume":"100","author":"Wu-Wong","year":"2007","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.bone.2009.01.011_bib8","doi-asserted-by":"crossref","first-page":"F8","DOI":"10.1152\/ajprenal.00336.2004","article-title":"Vitamin D","volume":"289","author":"Dusso","year":"2005","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.bone.2009.01.011_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2008.04.001","article-title":"Vitamin D analogs: Therapeutic applications and mechanisms for selectivity","author":"Brown","year":"2008","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.bone.2009.01.011_bib10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bone.2009.01.011_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfn502","article-title":"25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients","author":"Matias","year":"2008","journal-title":"Nephrol. Dial Transplant"},{"key":"10.1016\/j.bone.2009.01.011_bib12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1525-139X.2006.00120.x","article-title":"Vascular calcifications in uremia: old concepts and new insights","volume":"19","author":"Derici","year":"2006","journal-title":"Semin. Dial"},{"key":"10.1016\/j.bone.2009.01.011_bib13","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1161\/01.RES.0000249379.55535.21","article-title":"Vascular calcification: pathobiological mechanisms and clinical implications","volume":"99","author":"Johnson","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.bone.2009.01.011_bib14","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1681\/ASN.2007090993","article-title":"A bimodal association of vitamin D levels and vascular disease in children on dialysis","volume":"19","author":"Shroff","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2009.01.011_bib15","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2009.01.011_bib16","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/sj.ki.5001868","article-title":"Mortality risk among hemodialysis patients receiving different vitamin D analogs","volume":"70","author":"Tentori","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2009.01.011_bib17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ndt\/gfg513","article-title":"Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population","volume":"19","author":"Shoji","year":"2004","journal-title":"Nephrol. Dial Transplant"},{"key":"10.1016\/j.bone.2009.01.011_bib18","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: a historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2009.01.011_bib19","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2009.01.011_bib20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archinternmed.2007.110","article-title":"Association of activated vitamin D treatment and mortality in chronic kidney disease","volume":"168","author":"Kovesdy","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bone.2009.01.011_bib21","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1681\/ASN.2007111164","article-title":"Association of oral calcitriol with improved survival in nondialyzed CKD","volume":"19","author":"Shoben","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2009.01.011_bib22","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.RES.0000161997.24797.c0","article-title":"Regulation of vascular calcification: roles of phosphate and osteopontin","volume":"96","author":"Giachelli","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.bone.2009.01.011_bib23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1681\/ASN.2007080854","article-title":"Mechanisms of vascular calcification in chronic kidney disease","volume":"19","author":"Moe","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2009.01.011_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/01.mnh.0000172723.52499.38","article-title":"Vascular calcification","volume":"14","author":"Shanahan","year":"2005","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.bone.2009.01.011_bib25","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1111\/j.1523-1755.2005.00333.x","article-title":"Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD)","volume":"67","author":"Moe","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2009.01.011_bib26","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1161\/01.RES.87.7.e10","article-title":"Phosphate regulation of vascular smooth muscle cell calcification","volume":"87","author":"Jono","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.bone.2009.01.011_bib27","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1046\/j.1523-1755.2003.00820.x","article-title":"Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels","volume":"63","author":"Moe","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2009.01.011_bib28","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/ndt\/gfk008","article-title":"Up-regulation of Cbfa1 and Pit-1 in calcified artery of uraemic rats with severe hyperphosphataemia and secondary hyperparathyroidism","volume":"21","author":"Mizobuchi","year":"2006","journal-title":"Nephrol. Dial Transplant"},{"key":"10.1016\/j.bone.2009.01.011_bib29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/01.mnh.0000172719.26606.6f","article-title":"Fetuin-A and extraosseous calcification in uremia","volume":"14","author":"Ketteler","year":"2005","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.bone.2009.01.011_bib30","doi-asserted-by":"crossref","first-page":"20E","DOI":"10.1016\/S0002-9149(01)01718-0","article-title":"Insights into the mechanism of vascular calcification","volume":"88","author":"Bostrom","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.bone.2009.01.011_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfn226","article-title":"The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis","author":"Shroff","year":"2008","journal-title":"Nephrol. Dial Transplant"},{"key":"10.1016\/j.bone.2009.01.011_bib32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1159\/000124863","article-title":"The circulating inactive form of matrix Gla protein (ucMGP) as a biomarker for cardiovascular calcification","volume":"45","author":"Cranenburg","year":"2008","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.bone.2009.01.011_bib33","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1161\/01.HYP.13.6.954","article-title":"1,25-Dihydroxyvitamin D3 and rat vascular smooth muscle cell growth","volume":"13","author":"Carthy","year":"1989","journal-title":"Hypertension"},{"issue":"Suppl 2","key":"10.1016\/j.bone.2009.01.011_bib34","first-page":"117","article-title":"[Differential effect of vitamin D analogues on the proliferation of vascular smooth muscle cells]","volume":"23","author":"Cardus","year":"2003","journal-title":"Nefrologia."},{"key":"10.1016\/j.bone.2009.01.011_bib35","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/01.CIR.98.13.1302","article-title":"1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide","volume":"98","author":"Jono","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.bone.2009.01.011_bib36","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.070305","article-title":"Differential effects of vitamin D analogs on vascular calcification","volume":"22","author":"Cardus","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2009.01.011_bib37","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1124\/jpet.106.101261","article-title":"Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification","volume":"318","author":"Wu-Wong","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bone.2009.01.011_bib38","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1525-139X.2005.18407.x","article-title":"The role of vitamin D in vascular calcification in chronic kidney disease","volume":"18","author":"Wolisi","year":"2005","journal-title":"Semin. Dial"},{"key":"10.1016\/j.bone.2009.01.011_bib39","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/sj.ki.5000304","article-title":"1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway","volume":"69","author":"Cardus","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2009.01.011_bib40","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/01.hjh.0000166849.72721.1c","article-title":"Systemic cardiovascular disease in uremic rats induced by 1,25(OH)2D3","volume":"23","author":"Haffner","year":"2005","journal-title":"J. Hypertens."},{"key":"10.1016\/j.bone.2009.01.011_bib41","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/ndt\/gfh834","article-title":"1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar\/Mimpara) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism","volume":"20","author":"Henley","year":"2005","journal-title":"Nephrol. Dial Transplant"},{"key":"10.1016\/j.bone.2009.01.011_bib42","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1093\/ndt\/gfg296","article-title":"In subtotally nephrectomized rats 22-oxacalcitriol suppresses parathyroid hormone with less risk of cardiovascular calcification or deterioration of residual renal function than 1,25(OH)2 vitamin D3","volume":"18","author":"Hirata","year":"2003","journal-title":"Nephrol. Dial Transplant"},{"key":"10.1016\/j.bone.2009.01.011_bib43","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1681\/ASN.2005040342","article-title":"Calcimimetic R-568 decreases extraosseous calcifications in uremic rats treated with calcitriol","volume":"17","author":"Lopez","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2009.01.011_bib44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1254\/jphs.FPJ05019X","article-title":"Effect of etidronate on aortic calcification and bone metabolism in calcitriol-treated rats with subtotal nephrectomy","volume":"99","author":"Tamura","year":"2005","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.bone.2009.01.011_bib45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejphar.2006.12.006","article-title":"Prevention of aortic calcification by etidronate in the renal failure rat model","volume":"558","author":"Tamura","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bone.2009.01.011_bib46","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/sj.ki.5002028","article-title":"Uremia-related vascular calcification: more than apatite deposition","volume":"71","author":"Verberckmoes","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2009.01.011_bib47","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.ki.5002406","article-title":"Differential effects of vitamin D receptor activators on vascular calcification in uremic rats","volume":"72","author":"Mizobuchi","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2009.01.011_bib48","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfn375","article-title":"Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats","author":"Noonan","year":"2008","journal-title":"Nephrol. Dial Transplant"},{"key":"10.1016\/j.bone.2009.01.011_bib49","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1161\/01.CIR.96.6.1755","article-title":"Active serum vitamin D levels are inversely correlated with coronary calcification","volume":"96","author":"Watson","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.bone.2009.01.011_bib50","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/01.CIR.96.5.1477","article-title":"Ethnic origin and serum levels of 1alpha,25-dihydroxyvitamin D3 are independent predictors of coronary calcium mass measured by electron-beam computed tomography","volume":"96","author":"Doherty","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.bone.2009.01.011_bib51","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000190244","article-title":"Vascular calcification in long-term haemodialysis patients in a single unit: a retrospective analysis","volume":"77","author":"Goldsmith","year":"1997","journal-title":"Nephron"},{"key":"10.1016\/j.bone.2009.01.011_bib52","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1097\/01.ASN.0000129337.50739.48","article-title":"Arterial calcifications and bone histomorphometry in end-stage renal disease","volume":"15","author":"London","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2009.01.011_bib53","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ki.1994.380","article-title":"Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy","volume":"46","author":"Goodman","year":"1994","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2009.01.011_bib54","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0735-1097(01)01781-8","article-title":"Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?","volume":"39","author":"Raggi","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bone.2009.01.011_bib55","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/ndt\/gfl718","article-title":"Mineral metabolism parameters throughout chronic kidney disease stages 1\u20135\u2014achievement of K\/DOQI target ranges","volume":"22","author":"Craver","year":"2007","journal-title":"Nephrol. Dial Transplant"},{"key":"10.1016\/j.bone.2009.01.011_bib56","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2009.01.011_bib57","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jsbmb.2006.12.099","article-title":"1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte","volume":"103","author":"Nibbelink","year":"2007","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bone.2009.01.011_bib58","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1210\/en.2007-0805","article-title":"Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility","volume":"149","author":"Tishkoff","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2009.01.011_bib59","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000183125","article-title":"Uremic cardiomyopathy: potential role of vitamin D and parathyroid hormone","volume":"36","author":"McGonigle","year":"1984","journal-title":"Nephron."},{"key":"10.1016\/j.bone.2009.01.011_bib60","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0272-6386(99)70260-X","article-title":"Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism","volume":"33","author":"Park","year":"1999","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bone.2009.01.011_bib61","doi-asserted-by":"crossref","first-page":"E125","DOI":"10.1152\/ajpendo.00224.2004","article-title":"Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems","volume":"288","author":"Xiang","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328209000167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328209000167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T02:24:39Z","timestamp":1545445479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328209000167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":61,"alternative-id":["S8756328209000167"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2009.01.011","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}